Supply chain, logistics

90 Results

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Frontage Laboratories | 01-Dec-2019 | Technical / White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...

How to Avoid Surprises in Small-Molecule Drug Development Programs

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Assessing Pre-Existing Antibodies in Biotheraputic Development

Frontage Laboratories | 21-Aug-2019 | Technical / White Paper

Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...

The Truth about Physician Referrals and Clinical Trials

BBK Worldwide | 24-Jul-2019 | Technical / White Paper

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Marken | Recorded the 10-Oct-2018 | Webinar

Study protocols are increasingly complex with the need for extensive data collection despite complicated drug regimes. Patients may be deterred from taking...

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Survey Report: State of the global pharmaceutical contract services industry 2018

William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

Product Innovations

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Supply chain, logistics

90 Results

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

How to Avoid Surprises in Small-Molecule Drug Development Programs

Validating The Simoa Technology

Assessing Pre-Existing Antibodies in Biotheraputic Development

The Truth about Physician Referrals and Clinical Trials

Import Risks & Clinical Supply Depots

Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Discover Fermion’s new API unit 4 in Hanko

Survey Report: State of the global pharmaceutical contract services industry 2018

Suppliers

EVERSANA

Q2 Solutions

Baxter BioPharma Solutions

Marken

Ajinomoto Bio-Pharma Services

Frontage Laboratories

Follow us

Related News

Product Innovations

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Promotional Features

Free newsletter sign up

Outsourcing-Pharma

Resources